Sai Primus Lifebiotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 3.00 M
as on 16-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.88 Cr
as on 16-12-2024
- Revenue 37.77%
(FY 2022)
- Profit 57.10%
(FY 2022)
- Ebitda 37.97%
(FY 2022)
- Net Worth 56.84%
(FY 2022)
- Total Assets 5.71%
(FY 2022)
About Sai Primus Lifebiotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹28.88 Cr.
Ajay Narayanam, Srinivas Gangashettywar, Elangovan Srinivasan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304PY2017PTC008147
- Company No.
008147
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sai Primus Lifebiotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elangovan Srinivasan  | Managing Director | 24-Mar-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Narayanam | Director | 24-Mar-2017 | Current |
| Srinivas Gangashettywar | Director | 24-Mar-2017 | Current |
| Jonnalagadda Nagendraprasad | Director | 14-Sep-2024 | Current |
| Rakesh Pasupunuri | Director | 14-Sep-2024 | Current |
Financial Performance of Sai Primus Lifebiotech.
Sai Primus Lifebiotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.77% increase. The company also saw a substantial improvement in profitability, with a 57.1% increase in profit. The company's net worth Soared by an impressive increase of 56.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Primus Lifebiotech?
In 2023, Sai Primus Lifebiotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primus Remedies Private LimitedActive 14 years 9 monthsAjay Narayanam, Srinivas Gangashettywar and 2 more are mutual person
Lifecare Formulations Private LimitedActive 14 years 5 monthsElangovan Srinivasan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Oct 2024 | ₹15.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 May 2022 | ₹3.04 M | Open |
Indian Bank Creation Date: 11 May 2018 | ₹13.58 Cr | Open |
How Many Employees Work at Sai Primus Lifebiotech?
Sai Primus Lifebiotech has a workforce of 77 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Primus Lifebiotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Primus Lifebiotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
